A Novel Molecular Target in <i>EGFR</i>-mutant Lung Cancer Treated With the Combination of Osimertinib and PemetrexedNatsuki Takano, Akihiko Gemma|Anticancer Research|2022Cited by 9
A Novel Molecular Target in EGFR-Mutant Non-Small Cell Lung Cancer Treated With a Combination of Osimertinib and PemetrexedNatsuki Takano, Akihiko Gemma|Research Square|2021Cited by 0